The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 9.00
Ask: 9.50
Change: -0.65 (-6.74%)
Spread: 0.50 (5.556%)
Open: 9.50
High: 10.20
Low: 9.00
Prev. Close: 9.65
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

Thu, 13th May 2021 10:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

PHSC PLC, up 21% at 17.00 pence, 12-month range 7p-19.9p. Hits this 12-month high earlier on Thursday. The health & safety consulting firm expects revenue of GBP3.3 million for year to March 31, down from GBP4.4 million the year before, but underlying earnings before interest, taxes, depreciation and amortisation expected to rise to GBP520,000 from GBP255,000. Starts share buyback programme worth GBP325,000. "The company's board of directors has decided to effect the buyback programme, in part, due to the additional cash generated and held further to the successful disposal of the company's Essex property in late September 2018 for GBP305,000 gross and in light of the fact that PHSC's closing middle market share price as at May 12, being the latest practicable date prior to this announcement, of 14p represents a significant discount to its net asset value per share," it says.

----------

Goldstone Resources Ltd, up 19% at 13.80p, 12-month range 2.5p-15.49p. Says mining and ore stacking at the Homase Mine within Akrokeri-Homase gold project, Ghana, has commenced with the first mined ore having been successfully stacked onto the heap leach pad. "This is a pivotal step in the evolution of the company as we start production of the Homase Mine. Commencement of operations will lead to an ongoing revenue stream and will also establish a base for unlocking value in our AKHM project," says Chief Executive Emma Priestley.

----------

AIM - LOSERS

----------

Best of the Best PLC, down 14% at 2,665p, 12-month range 556.92p-3,570p. Says revenue and pretax profit for financial year ended April 30 to be in line with market expectations, which were raised in March. Even with Thursday's decline, shares still up 86% since start of 2021 and have grown more than four-fold over past 52 weeks.

----------

e-Therapeutics PLC, down 11% at 25.53p, 12-month range 1.01p-33p. The drug discovery company reports pretax loss of GBP4.5 million for year to January 31, widening from GBP2.9 million the year before. Widened loss largely due to administrative costs rising to GBP2.1 million from GBP1.2 million, with a management restructure in February 2020 resulting in one-off redundancy costs of GBP400,000. "Although we are not expecting the same level of one-off expenditure, we are expecting the underlying cost base to increase as the business continues to grow," company says.

----------

Online Blockchain PLC, down 10% at 41.43p, 12-month range 11p-127.5p. The blockchain research and development company falls after Tesla hit the brakes on letting people pay for electric cars with bitcoin, saying the computing-intense mining process of creating new cryptocurrency spews climate-harming emissions. "We are concerned about rapidly increasing use of fossil fuels for bitcoin mining and transactions, especially coal, which has the worst emissions of any fuel," Tesla Chief Executive Elon Musk says in a tweet. "Cryptocurrency is a good idea on many levels and we believe it has a promising future, but this can not come at great cost to the environment." The cryptocurrency initially tumbled after Musk's tweet, before recovering slightly to around USD50,773 early Thursday, according to cryptocurrency news outlet Coindesk. Main Market-listed cryptocurrency mining firm Argo Blockchain falls 11%.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 Oct 2013 11:57

UK WINNERS & LOSERS: Hargreaves Continues To Rise, e-Therapeutics Trips

Read more
16 Oct 2013 08:56

e-Therapeutics Pretax Loss Widens As R&D Expenditure Rises

Read more
30 Sep 2013 18:45

DIRECTOR DEALINGS: E-Therapeutics Exec, Wife Combined Shares Total 1.8M

Read more
24 Jul 2013 15:53

Wife of DS Smith CEO sells 5.6m-pound stake

The wife of DS Smith frontman Miles Roberts sold a substantial sum of shares in the packaging and office supplies firm on the same day it was revealed the Chief Executive Officer (CEO) received a big pay increase last year. The move came on Tuesday, the same day DS Smith released its annual report

Read more
14 May 2013 09:46

e-Therapeutics pleases with pipeline progress

News from biotech company e-Therapeutics about the progress of two clinical trials for its cancer drug pleased the markets on Tuesday. The AIM-listed company provided first findings for the company's ETS2101 drug candidate in Phase I trials in the US for patients with brain cancer and in the UK fo

Read more
14 May 2013 08:04

Tuesday broker round-up UPDATE

Babcock International: Jefferies increases target price from 1080p to 1250p and maintains a buy recommendation. Barratt Developments: Bank of America takes target price from 265p to 325p, while downgrading to neutral. Belgravium Technologies: WH Ireland places both its target price and its neutral

Read more
10 May 2013 07:14

Friday broker round-up UPDATE

Afren: Westhouse Securities initiates with a target price of 160p and a buy recommendation. Ashmore Group: Credit Suisse raises target price from 375p to 440p upgrading from underperform to neutral. Barratt Developments: Citigroup increases target price from 245p to 315p leaving its neutral rating

Read more
19 Feb 2013 16:21

Debenhams Executive Director adds to stake

Michael Sharp, the Executive Director of retail chain Debenhams, has topped up his stake in the group with the purchase of 50,000 shares. Sharp, who has been in his current role since September 2011, bought the shares at 97.20p for a total of £48,598. He now holds 6.2m shares in the company. Debe

Read more
11 Feb 2013 09:15

e-Therapeutics shares jump following 40m equity issue

Drug discovery and development company e-Therapeutics is proposing to raise 40m pounds through an issue of new ordinary shares to existing and new institutional investors. The new shares will be priced at 32p, a premium of 4.0% to the closing mid-market price on Friday. Following the proposed issu

Read more
23 Oct 2012 09:23

Tuesday broker round-up

Aggreko: UBS cuts target from 2,750p to 2,550p, buy rating kept. ARM Holdings: Investec keeps buy rating and 800p target. Avacta: Panmure Gordon keeps buy rating and 1.75p target. AZ Electronic: Canaccord Genuity ups target from 360p to 376p, buy rating kept. Babcock: JPMorgan Cazenove ups targe

Read more
22 Oct 2012 08:19

Monday broker round-up - UPDATE

888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept. Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating kept; HSBC downgrades to underweight, target cut from 2,350p to 1,750p; JPMorgan Cazenove cuts target from 2,360p to 2,165p, neutral rating kept; Barcl

Read more
22 Oct 2012 07:53

e-therapeutics produces mixed interims

e-therapeutics, a drug discovery and development company, produced mixed interims with slightly increased losses, but reported progress on its lead cancer drug. As expected, first half losses increased to £1.8m (2011: loss of £1.5m), reflecting increased investment in the business. The company ha

Read more
15 Mar 2011 17:05

Bramson vehicle buys more shares in F&C

F&C Asset Management chairman Edward Bramson's investment vehicle SIGA LP has acquired more shares in the asset management company. Bramson was appointed chairman of F&C last month after a shareholder coup removed the previous incumbent, along with another non-executive, and appointed three new di

Read more
14 Mar 2011 17:19

Wife of outgoing FD sells British Land shares

Diane Roberts, the wife of British Land finance director Graham Roberts, has raised more than £1m by selling more than three-quarters of the couple's stake in the property investor. She sold 191,780 shares at 562.8p each, which raised £1.08m. The couple are left with 50,464 shares in British Land.

Read more
4 Mar 2011 17:03

Shaftesbury boss invests £100,000

Shaftesbury chief executive Jonathan Lane has invested a further £100,000 in the property investor. Lane has bought 22,222 shares at 450p each. That takes his stake to 966,233 shares, which is worth £4.3m at the latest purchase price. Lane raised just over £99,000 from the sale of option shares la

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.